Clinical Trial Update: Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA [Phase 1]

View source ↗

Summary

A Phase 1a/b tolerability update on the investigational drug NTR-1011 in healthy adults and patients with systemic lupus erythematosus or rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis
• Systemic Lupus Erythematosus

Drugs mentioned

• NTR-1011

Snippet

Sponsor: Neutrolis | Conditions: SLE (Systemic Lupus), RA - Rheumatoid Arthritis | Phase 1 | Status: COMPLETED